Papers
Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea
BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7414.523 (Published 04 September 2003) Cite this as: BMJ 2003;327:523
Related articles
- Editor's Choice Published: 04 September 2003; BMJ 327 doi:10.1136/bmj.327.7414.0-g
- This Week In The BMJ Published: 04 September 2003; BMJ 327 doi:10.1136/bmj.327.7414.0-a
- Practice Published: 20 July 2006; BMJ 333 doi:10.1136/bmj.333.7560.188
- ResearchSafety of benzodiazepines and opioids in very severe respiratory disease: national prospective studyPublished: 30 January 2014; BMJ 348 doi:10.1136/bmj.g445
- Clinical Review Published: 02 January 2015; BMJ 349 doi:10.1136/bmj.g7617
- Endgames Published: 24 October 2014; BMJ 349 doi:10.1136/bmj.g6435
- Letter Published: 27 November 2003; BMJ 327 doi:10.1136/bmj.327.7426.1288-b
- Student Published: 14 July 2016; BMJ 354 doi:10.1136/sbmj.h6200
See more
- GLP-1 agonists may raise risk of pulmonary aspiration during surgery, MHRA warnsBMJ January 30, 2025, 388 r205; DOI: https://doi.org/10.1136/bmj.r205
- Anaesthetist shortage is preventing over a million operations a year, warns royal collegeBMJ November 20, 2024, 387 q2575; DOI: https://doi.org/10.1136/bmj.q2575
- Anaesthetists feel broadly negative about associates, survey findsBMJ April 10, 2024, 385 q839; DOI: https://doi.org/10.1136/bmj.q839
- Cardiac arrest occurs in three in 10 000 surgeries involving anaesthesia, audit findsBMJ November 20, 2023, 383 p2737; DOI: https://doi.org/10.1136/bmj.p2737
- Anaesthesia associates: Royal college convenes extraordinary meeting after call from membersBMJ September 11, 2023, 382 p2076; DOI: https://doi.org/10.1136/bmj.p2076
Cited by...
- Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis
- European Respiratory Society clinical practice guideline on symptom management for adults with serious respiratory illness
- Sensory interventions to relieve dyspnoea in critically ill mechanically ventilated patients
- Effectiveness and safety of morphine administration for refractory dyspnoea among hospitalised patients with advanced heart failure: the Morphine-HF study
- Chronic breathlessness in advanced cardiorespiratory disease: patient perceptions of opioid use
- Effectiveness and safety of morphine administration for refractory dyspnoea among hospitalised patients with advanced heart failure: the Morphine-HF study
- Missing data in palliative care research: estimands and estimators
- Patients and their caregivers experiences with regular, low-dose, sustained-release morphine for chronic breathlessness associated with COPD: a qualitative study
- Morphine for dyspnoea in chronic obstructive pulmonary disease: a before-after efficacy study
- Study protocol for a randomised, placebo-controlled, single-blind phase II study of the efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15)
- Indications and patterns of use of benzodiazepines and opioids in severe interstitial lung disease: a population-based longitudinal study
- Opioids for breathlessness: a narrative review
- Minimal clinically important differences in average, best, worst and current intensity and unpleasantness of chronic breathlessness
- Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial
- Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial
- Systematic review of general practice end-of-life symptom control
- Chronic breathlessness: time for Cinderella to go to the ball!
- British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
- One evidence base; three stories: do opioids relieve chronic breathlessness?
- Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis
- Respiratory Sensations in Dynamic Hyperinflation: Physiological and Clinical Applications
- A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol
- Prescription opioid use in advanced COPD: benefits, perils and controversies
- Prescription opioid use in advanced COPD: benefits, perils and controversies
- Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness
- Study protocol: a phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people with chronic breathlessness
- Opioids in COPD: a cause of death or a marker of illness severity?
- Incident opioid drug use and adverse respiratory outcomes among older adults with COPD
- Managing breathlessness: a palliative care approach
- The need to research refractory breathlessness
- End-of-life care in oxygen-dependent COPD and cancer: a national population-based study
- Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
- Practical management of chronic breathlessness
- Low-dose opioids should be considered for symptom relief also in advanced chronic obstructive pulmonary disease (COPD)
- Measuring improvement in dyspnoea: should absolute or relative values be used?
- Randomised controlled trials: "within subject" versus "between subject" designs
- Building the Palliative Care Evidence Base: Lessons From a Randomized Controlled Trial of Oxygen vs Room Air for Refractory Dyspnea
- Doctors' attitudes towards prescribing opioids for refractory dyspnoea: a single-centred study
- Managing breathlessness in advanced disease
- Pharmacotherapy During the End of Life: Caring for the Actively Dying Patient
- The active identification and management of chronic refractory breathlessness is a human right
- Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study
- The management of chronic breathlessness in patients with advanced and terminal illness
- Evidence-based intervention for chronic refractory breathlessness: practical therapies that make a difference
- Opioids for chronic refractory breathlessness: patient predictors of beneficial response
- Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients' experiences and outcomes
- Palliative care in COPD patients: is it only an end-of-life issue?
- Attitudes to morphine in chronic heart failure patients
- Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease
- Attitudes to morphine in chronic heart failure patients
- Symptom Management in Metastatic Breast Cancer
- Palliative Care in the Treatment of Advanced Heart Failure
- Palliation of dyspnoea in advanced COPD: revisiting a role for opioids
- End-of-life care for patients with COPD in the community setting
- Series on comprehensive management of end-stage COPD
- Primary care and palliative care
- The use of opioids for palliative care in refractory dyspnoea
- Morphine for management of refractory dyspnoea: Opiates should be used with caution
- Managing Refractory Dyspnea with Morphine